Resveratrol attenuates oxidative stress and improves behaviour in 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice

被引：38

作者：

Anandhan, Annadurai ^{[1
]}

Tamilselvam, Kuppusamy ^{[1
]}

Vijayraja, Dhanraj ^{[1
]}

Ashokkumar, Nataraj ^{[1
]}

Rajasankar, Srinivasagam ^{[2
]}

Manivasagam, Thamilarasan ^{[1
]}

机构：

[1] Annamalai Univ, Fac Sci, Dept Biochem & Biotechnol, Annamalainagar, Tamil Nadu, India

[2] Melmaruvathur Adhi Parasakthi Inst Med Sci, Dept Anat, Melmaruvathur, Tamil Nadu, India

来源：

ANNALS OF NEUROSCIENCES | 2010年 / 17卷 / 03期

关键词：

Behaviour; Dopamine; MPTP; Oxidative stress; Parkinson's disease; Resveratrol;

D O I：

10.5214/ans.0972-7531.1017304

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Background: Parkinson's disease (PD) is the most common neurodegenerative disorder, characterized by loss of dopaminergic neurons in substantia nigra and depletion of dopamine in striatum due to mitochondrial dysfunction, oxidative stress, excitotoxicity, apoptosis, inflammation and proteasome failure. Purpose: The present study deals with the neuroprotective effect of resveratrol, a wine polyphenol (50 mg/kg body weight) against MPTP (30mg/kg body weight as i.p. administration) induced mice model of idiopathic Parkinson's disease. Methods: A combination of behaviour tasks and biochemical parameters were tested using standard molecular tools. Results: Pretreatment of resveratrol significantly reversed toxic effects of MPTP by increasing the levels of dopamine, its metabolites, GSH and activities of GPx and reducing levels of TBARS, catalase and SOD activities along with enhanced behavior performance. Conclusion: The multifactorial etiology of these diseases suggests that drugs with multiple targets such as resveratrol could have therapeutic potential for these pathologies.

引用

页码：113 / 119

页数：7

共 62 条

[1]

AEBI H, 1984, METHOD ENZYMOL, V105, P121

[2]

AGID Y, 1993, ADV NEUROL, V60, P148

[3]

Alam ZI, 1997, J NEUROCHEM, V69, P1326

[4] Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases [J].

Alexi, T ;

Borlongan, CV ;

Faull, RLM ;

Williams, CE ;

Clark, RG ;

Gluckman, PD ;

Hughes, PE .

PROGRESS IN NEUROBIOLOGY, 2000, 60 (05) :409-470

[5] Comparative analysis of the effects of resveratrol in two apoptotic models:: Inhibition of complex I and potassium deprivation in cerebellar neurons [J].

Alvira, D. ;

Yeste-Velasco, M. ;

Folch, J. ;

Verdaguer, E. ;

Canudas, A. M. ;

Pallas, M. ;

Camins, A. .

NEUROSCIENCE, 2007, 147 (03) :746-756

[6] Sustained inhibition of brotizolam induced anterograde amnesia by norharmane and retrograde amnesia by L-glutamic acid in mice [J].

Anand, Akshay ;

Saraf, Manish Kumar ;

Prabhakar, Sudesh .

BEHAVIOURAL BRAIN RESEARCH, 2007, 182 (01) :12-20

[7] Neuroprotection in Parkinson models varies with toxin administration protocol [J].

Anderson, David W. ;

Bradbury, Kristin A. ;

Schneider, Jay S. .

EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 24 (11) :3174-3182

[8] Resveratrol - A boon for treating Alzheimer's disease? [J].

Anekonda, Thimmappa S. .

BRAIN RESEARCH REVIEWS, 2006, 52 (02) :316-326

[9]

Banik A, 2000, BEHAV BRAIN RES, DOI [10.1016/j.bbr.2010.07035, DOI 10.1016/J.BBR.2010.07035]

[10] Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons [J].

Bastianetto, S ;

Zheng, WH ;

Quirion, R .

BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (04) :711-720

← 1 2 3 4 5 6 7 →